Big pharma in HR+/HER2− BC

37 of the 50 largest pharma companies have at least one HR+/HER2− BC activity: 350 programs, deals, investments and trial collaborations.

Timeline

One mark per activity, in the row of its type, at the date named in the row label. Color = drug type (trial support = Repurposing; investment = the target company's drug type); mark style = status. Click a mark for details.

← Scroll to see all years →

Involvement by company

Pharma 50 rank = Drug Discovery & Development, Pharma 50 2026, by FY2025 pharmaceutical revenue. Click a company to focus every view on it; click a column header to sort.

← Scroll to see all activity types →

Programs, deals and trial support

Rows = activity type, columns = current stage of the program or trial. Chips sorted by Pharma 50 rank.

← Scroll to see all stages →

Investments

Investments by a company or its venture arm, by round stage. Chips sorted by year; amounts = total round size.

← Scroll to see all round stages →